European Heart Journal-Quality of Care and Clinical Outcomes

Article	Citations
Call for emergency action to limit global temperature increases, restore biodiversity, and protect health	91
Ambulance drive-thru troponin, ready to go?	48
Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention	42
Radial first for STEMI and cardiogenic shock: Jumping in the water with your wrists tied	36
Letter to the editor in response to Kobo et al. 2022	35
Implementing rapid algorithms for high-sensitivity troponin—economic benefits and caveat emptor	34
Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis	32
Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease	32
Long-term aspirin adherence following myocardial infarction and risk of cardiovascular events	31
Secundum atrial septal defect closure in adults in the UK	30
Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines	29
Alcoholic cardiomyopathy-attributed mortality in Europe, 2012–20	28
Key priorities for the implementation of the 2023 ESC Guidelines for the management of acute coronary syndromes in low-resource settings	27
The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetes	27
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiomyopathies in low-resource settings	26
Hypertrophic cardiomyopathy management: a systematic review of the clinical practice guidelines and recommendations	26
Quality of life and the assessment of surgical quality	25
Fifteen-year secular changes in the care and outcomes of patients with out-of-hospital cardiac arrest in Japan: a nationwide, population-based study	24
Influence of multiple risk factor control level on cardiovascular outcomes in hypertensive patients	23
Correction to: Trends in risk factors among young patients with acute myocardial infarction: a nationwide cohort study	22
Cost-effectiveness of population screening for aortic stenosis	22
Post-discharge pharmacotherapy in people with atrial fibrillation hospitalized for acute myocardial infarction: an Australian cohort study 2018–22	21
Mapping the modern heart failure epidemic: Growing burden, root causes and widening inequalities	21
Economic burden of cardiovascular disease in the United Kingdom	21
Contemporary trends in incident ischaemic stroke, intracranial haemorrhage, and mortality in individuals with atrial fibrillation	20

Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials	20
Impact of low physical activity on cardiovascular disease across regions and demographic groups: insights from the Global Burden of Disease Study	20
Letter to the editor in response to Sengupta et al. (2022)	19
Erratum to: Economic burden of patients living with heart disease in the last years of life in Australia: a retrospective analysis using linked data	19
Risk-standardized mortality metric to monitor hospital performance for chest pain presentations	18
Rapid Assessment and Treatment In Decompensated Aortic Stenosis (ASTRID-AS study)- A pilot study	18
Heart failure with preserved ejection fraction management: a systematic review of clinical practice guidelines and recommendations	17
Association of cumulative health status with subsequent mortality in patients with acute heart failure	17
Cancer and the risk of perioperative arterial ischaemic events	17
Cohort profile: Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal cohort	17
Greenness exposure and mortality risk in a cardio-oncologic population	17
The beginning of wisdom is the definition of terms: counting heart failure hospitalizations	17
Estimated annual healthcare costs after acute pulmonary embolism: results from a prospective multicentre cohort study	16
Prognostic impact of anaemia in patients undergoing aortic valve replacement: a nationwide study	15
Standardized and hierarchically classified heart failure and complementary disease monitoring outcome measures: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)	15
Predictive and prognostic value of different cardiac troponin assays: a nationwide register-based cohort study	14
Clinical Outcomes in Hospitalized Patients with Cancer and New versus Preexistent Atrial Fibrillation	14
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry	14
Machine learning for prediction of all-cause mortality after transcatheter aortic valve implantation	14
A decade of follow-up: atrial fibrillation, pulmonary pressure, and the progression of tricuspid regurgitation	14
Transcatheter vs. surgical mitral valve interventions in patients with prior coronary artery bypass grafting	13
Periprocedural myocardial infarction after coronary artery bypass grafting: defining what matters	13
Hospital admissions in the last year of life of patients with heart failure	13
The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study	13
Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly	13
Comparative efficacy and safety of different catheter ablation strategies for persistent atrial fibrillation: a network meta-analysis of randomized clinical trials	13
Association between Early Oral β-Blocker Therapy and Risk for In-Hospital Major Bleeding after Percutaneous Coronary Intervention for Acute Coronary Syndrome: Findings from CCC-ACS Project	12
Safety of AF ablation–its evolution over time and lessons from down under	12
Bacteraemia and infective endocarditis following left-sided heart valve surgery	12
Predicted clinical and economic burden associated with reduction in access to acute coronary interventional care during the COVID-19 lockdown in two European countries	12
Suspected Non-ST-elevation acute coronary syndrome meeting rapid rule-out criteria: resource utilization, diagnostic yield, and clinical outcomes of hospital admission	11
Corrigendum to: Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials	11
Current epidemiology and management of acute heart failure: the multicenter prospective OFICA2 cohort	11
Global, regional, and national burden of atrial fibrillation/flutter related to metabolic risks over three decades: estimates from the global burden of disease study 2019	11
National health expenditure per capita is associated with CRT implantation practice: findings from the ESC CRT Survey II with 11 088 patients	11
Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE-MD (Coordinating Research and Evidence for Medical Devices)	11
Incidence, predictors, and prognostic impact of rehospitalization after transcatheter aortic valve implantation	11
Association of baseline and changes in health-related quality of life with mortality following myocardial infarction: multicentre longitudinal linked cohort study	11
Quality of life and societal costs in patients with dilated cardiomyopathy	11
Trends and projections of heart failure among adolescents and young adults: an in-depth analysis for the Global Burden of Disease Study 2021	11
Tricuspid regurgitation management: a systematic review of clinical practice guidelines and recommendations	11
Implantable cardioverter defibrillators in heart failure with reduced ejection fraction after myocardial infarction: the need for contemporary evidence	11
Non-invasive physiological assessment of intermediate coronary stenoses from plain angiography through artificial intelligence: the STARFLOW system	10
Renin–angiotensin system inhibition and in-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction: findings from CCC-ACS project and a nationwide electronic health reco	10
Impact of COVID-19 pandemic on the incidence and prevalence of postural orthostatic tachycardia syndrome	10
Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Re	10
Optimizing anticoagulant therapy: is pharmacist-led intervention the best	10
Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017–2019	10
Has the first year of the COVID-19 pandemic reversed the trends in CV mortality between 1999 and 2019 in the United States?	10
Reperfusion strategies on the clinical outcomes of ST-elevation myocardial infarction patients over 80 years old in China	9

Heart failure in an ageing world: closing the evidence-equity gap	9
Trends in atrial fibrillation-related mortality in Europe, 2008–2019	9
Quality of care and long-term survival after ST-elevation myocardial infarction in adults with cancer	9
Current management of transition and multidisciplinary care of patients with inherited and rare cardiomyopathies in Europe: results of the European Reference Network for rare and low prevalence comple	9
Cohort profile: the prospective cohort study on the incidence of metabolic diseases and risk factors in Shunde, China (Speed-Shunde cohort)	9
Temporal trends in loss of expected lifetime associated with cardiovascular complications following newly diagnosed atrial fibrillation: a Danish nationwide cohort study from 2000 to 2022	9
Discharge after primary percutaneous coronary intervention: the earlier the better?	8
Left ventricular thrombus in ischaemic heart disease: diagnosis, treatment, and gaps of knowledge	8
Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study	8
Comprehensive risk factor management for hypertensive patients	8
Regional disparities in heart transplant mortality in the USA	8
Trends and risk factors analysis of aortic aneurysm mortality in China over thirty years: based on the global burden of disease 2019 data	8
Association of atrial fibrillation with survival in patients with low-flow low-gradient aortic stenosis with preserved ejection fraction undergoing TAVI	8
Transcatheter aortic valve replacement in mixed aortic valve disease: a systematic review and meta-analysis	8
Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence	8
Adapting predictive risk models and preventive strategies across different socio-economic regions to reduce global cardiovascular burden	8
Diagnostic accuracy, clinical characteristics, and prognostic differences of patients with acute myocarditis according to inclusion criteria	8
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settings	7
Remnant cholesterol and risk of premature mortality: an analysis from a nationwide prospective cohort study	7
Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040	7
The patient journey in chronic coronary syndromes with/without obstructive coronary arteries	7
Rigour of development of European Society of Cardiology, American College of Cardiology and American Heart Association guidelines over a 12-year period (2013–2024): a systematic review of guidelines	7
The burden of atrial fibrillation related to metabolic risks: different countries and territories, yet the same challenges	7
Impact of the method of calculating 30-day readmission rate after hospitalization for heart failure. Data from the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry	7
Existing heath disparities in congenital heart disease: the path forward to achieving health equity—A scientific statement of the European Association of Preventive Cardiology of the ESC	7
Assessing the health impact of low seafood omega-3 intake on ischaemic heart disease: trends, demographic disparities, and forecasts	7
Safety and efficacy of direct oral anticoagulants in patients with anaemia and atrial fibrillation: an observational nationwide Danish cohort study	7
Machine learning-based identification of risk-factor signatures for undiagnosed atrial fibrillation in primary prevention and post-stroke in clinical practice	7
Impact of intravascular ultrasound for coronary bifurcations treated with last-generation stents: insights from the ULTRA-BIFURCAT registry	6
The Italian Fabry Disease Cardiovascular Registry (IFDCR)	6
Importance of diagnostic setting in determining mortality in patients with new-onset heart failure: temporal trends in Denmark from 1997 to 2017	6
Global burden of heart failure in older adults: trends, socioeconomic inequalities, and future projections from 1990 to 2035	6
Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapies	6
Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990–2019	6
Cost-effectiveness analysis of screening for first-degree relatives of patients with bicuspid aortic valve	6
Change in prevalence of ATTR variants in Italy: results from a national survey	6
Economic evaluation of the Liverpool heart failure virtual ward model	6
Global, regional, and national burden of pulmonary arterial hypertension and related heart failure from 1990 to 2021, with predictions to 2050: insights from the global burden of disease study 2021	6
A systematic assessment of the characteristics of randomized controlled trials cited by acute coronary syndrome clinical practice guidelines	6
Relationship between hospital mortality and readmission rates after transcatheter aortic valve replacement	6
Psoriasis and risk of new-onset degenerative valvular heart disease: a prospective cohort study	6
Association of socioeconomic status in the incidence, quality-of-care metrics, and outcomes for patients with cardiogenic shock in a pre-hospital setting	6
Should we routinely measure patient quality of life after acute coronary syndrome?	5
Trends in risk factors among young patients with acute myocardial infarction: a nationwide cohort study	5
Driving restrictions following defibrillator implantation: a nationwide register-linked survey study on the impact on employment, daily living, and driving behaviour	5
Implications of structural right ventricular involvement in patients with hypertrophic cardiomyopathy	5
New European Union law on medical devices: will it truly protect patients from malfunctioning cardiac implantable electronic devices?	5
Cardiovascular disease burden due to productivity losses in European Society of Cardiology countries	5
De-frailing intervention for hospitalized cardiovascular patients in the TARGET-EFT randomized clinical trial	5
Cardiopulmonary long-term effects 30 months after severe COVID-19 infection	5
Aortic regurgitation management: a systematic review of clinical practice guidelines and recommendations	5
Representativeness in randomised clinical trials supporting acute coronary syndrome guidelines	5
Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands	5
Mental health and anticoagulant prescription in atrial fibrillation	5
Catheter ablation as an adjunctive therapy to ICD implantation in Brugada Syndrome	5
Update on long-term cardiovascular risk after pre-eclampsia: a systematic review and meta-analysis	5
Incidence of myocardial infarction, heart failure, and cardiovascular mortality in patients with peripheral artery disease: trends between 1997 and 2016	5
Correspondence to the European Heart Journal – Quality of Care and Clinical Outcomes in response to the paper by Warming et al. (2022): Atrial fibrillation and chronic obstructive pulmonary disease: d	5
Association of healthy sleep pattern with risk of recurrent cardiovascular events among patients with coronary heart disease	5
Primary prevention ICD: essential safeguard or personalized selectivity?	5
Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 2019	5
Correspondence to the European Heart Journal—Quality of Care and Clinical Outcomes in response to the paper by Thygesen et al. (2021)	5
Trends in ST-elevation myocardial infarction hospitalization among young adults: a binational analysis	5
Transradial versus transfemoral approach for percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a systematic review and meta-analy	5
Inclusion and reporting by age, sex, and ethnicity in clinical studies of high-risk medical devices approved in the European Union	5
Mechanical Circulatory Support Devices versus Standard Medical Therapy for Treatment of Myocardial Infarction Complicated by Cardiogenic Shock: a Network Meta-Analysis	4
The controversy between atrial fibrillation subtypes and worsening heart failure	4
Targeted atrial fibrillation detection in COVID-19 vaccination clinics	4
Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis)	4
Corrigendum to: Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF Gene	4
Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 2019	4
Comparison of mitral valve repair vs. replacement for mitral valve regurgitation	4
Management of mitral stenosis: a systematic review of clinical practice guidelines and recommendations	4
Psychiatric morbidity and work participation in patients with congenital ventricular septal defects: a case-controlled study	4
Feasibility of coronary access after transcatheter aortic valve implantation (TAVI): a systematic review and meta-analysis of observational studies	4
A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-making	4
Acute coronary occlusion with vs. without ST elevation: impact on procedural outcomes and long-term all-cause mortality	4
Predicting new-onset heart failure hospitalization of patients with atrial fibrillation: development and external validations of a risk score	4
Data standards for atrial fibrillation/flutter and catheter ablation: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)	4
Association between cancer, CHA2DS2VASc risk, and in-hospital ischaemic stroke in patients hospitalized for atrial fibrillation	4

A hidden problem: peripheral artery disease in women	4
Editorial: Beyond obesity: metabolic status as key driver for cardiovascular outcomes in patients undergoing invasive coronary angiography	4
COP27 Climate Change Conference: urgent action needed for Africa and the world	4
Impact of the admitting ward on care quality and outcomes in non-ST-segment elevation myocardial infarction: insights from a national registry	4
The impact of atrial fibrillation on prognosis in aortic stenosis	4
An early accumulation of serum uric acid confers more risk of heart failure: a 10-year prospective cohort study	4
Vaccines and myocardial injury in patients hospitalized for COVID-19 infection: the CardioCOVID-Gemelli study	4
Letter to the Editor in Response to Sengupta et al. (2022)	4
Atrial fibrillation—lost lifetimes and the urgent need for outcome-driven management	4
The association of temporal sequence in atrial fibrillation and chronic obstructive pulmonary disease diagnosis and mortality risk: Reply	4
Heart failure clinical registries vs. registering the reality of heart failure	4
The first International Consortium for Health Outcomes Measurement (ICHOM) standard dataset for reporting outcomes in heart valve disease: moving from device- to patient- centered outcomes	4
Atrial fibrillation screening and clinical outcomes: a meta-analysis of randomized controlled trials	4
Long-term cardiovascular disease after pre-eclampsia: time to move from epidemiology to action	4
Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk	4
β-blocker adherence among patients with congenital long QT syndrome: a nationwide study	3
Clinical and genetic diagnosis of familial hypercholesterolaemia in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study	3
Specialist services for cardiomyopathy: quality care requires diagnostic accuracy	3
The quality of care and long-term mortality of out of hospital cardiac arrest survivors after acute myocardial infarction: a nationwide cohort study	3
Cost-effectiveness of intravascular ultrasound-guided percutaneous intervention in patients with acute coronary syndromes: a UK perspective	3
Beyond obesity: metabolic status as a key driver for cardiovascular outcomes in patients undergoing invasive coronary angiography	3
Longitudinal risk of death, hospitalizations for atrial fibrillation, and cardiovascular events following catheter ablation of atrial fibrillation: a cohort study	3
The cardiovascular disease burden attributable to kidney dysfunction from 1990 to 2021: an age–period–cohort analysis of the Global Burden of Disease study	3
The evolving landscape of atrial fibrillation: diagnosis and therapy	3
Preparation for cardiac procedures: a cross-sectional study identifying gaps between outpatients’ views and experiences of patient-centred care	3
Educational inequalities in cardiovascular diseases and their mediating factors across different generations: a prospective cohort study	3
Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI	3
High risk of rehospitalization within 1 year following a pulmonary embolism—insights from the Danish nationwide registries from 2000–2020	3
Aiming at a Better Guidance in the Post-Pulmonary Embolism Syndrome Management: Is the Gap Fully Filled Out?	3
The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial	3
Adherence to perindopril/amlodipine/atorvastatin combination according to the administration strategy	3
Prognostic value of weight loss in hospitalized patients with heart failure	3
Corrigendum to: Cohort profile: Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal cohort	3
Withdrawn as duplicate: Quality of life and the assessment of surgical quality	3
Global, regional, and national burden of heart failure and its risk factors between 1990 and 2021 and projections to 2050: an analysis of the global burden of disease study	3
Risk of incident cardiovascular disease among patients with gastrointestinal disorder: a prospective cohort study of 330 751 individuals	3
Types of myocardial injury and mid-term outcomes in patients with COVID-19	3
Effect of coronary artery bypass grafting on quality of life: a meta-analysis of randomized trials	3
Clinicoeconomic burden among heart failure patients with severely reduced ejection fraction after hospital admission: HF-RESTORE	3
Association of socioeconomic status with 30-day survival following out-of-hospital cardiac arrest in Scotland, 2011–2020	3
Assessment of the safety and efficacy of catheter ablation for atrial fibrillation in very elderly patients: insight from the national prospective registry study	3
Reduced access to primary care for immigrants increases cardiovascular complications and hospital admissions: the importance of information and education	3
European Society of Cardiology quality indicators for the care and outcomes of adults undergoing transcatheter aortic valve implantation	2
Key priorities for the implementation of the 2023 ESC Guidelines for the management of endocarditis in low-resource settings	2
Temporal trend analysis of rheumatic heart disease burden in high-income countries between 1990 and 2019	2
Effects of the COVID-19 pandemic on secondary care for cardiovascular disease in the UK: an electronic health record analysis across three countries	2
Sex differences in clinical profile, management, and outcomes of patients hospitalized for atrial fibrillation in the United States	2
Global burden of heart failure and its underlying causes in 204 countries and territories, 1990–2021	2
What really matters: a patient-centered instrument to evaluate health-related quality of life in cardiovascular disease	2
Does Down syndrome influence the outcomes of congenital cardiac surgery? A systematic review and meta-analysis	2
Trends in treatment and outcomes of atrial fibrillation during 2007–17 in Finland	2
Corrigendum to: Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials	2
Uptitration of statin therapy in women and men: a population-based cohort study	2
Association of acute increases in serum creatinine with subsequent outcomes in patients with type 2 diabetes mellitus treated with sodium–glucose cotransporter 2 inhibitor or dipeptidyl peptidase-4 in	2
Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study	2
Corrigendum to: Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)	2
Generalizability of randomized controlled trials in heart failure with reduced ejection fraction	2
Long-term survival after transcatheter aortic valve implantation in the modern era compared with the general population – a Nationwide Danish Cohort Study	2
Impact of age on outcomes after transcatheter aortic valve implantation	2
Letter to the editor in response to Kobo et al. (2022)	2
The European Heart Journal. Quality of Care and Clinical Outcome in the years to come: a salutation from the incoming Editor-in-Chief	2
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus: Reply	2
Health Outcomes Management Evaluation—A National Analysis of Dutch Heart Care	2
Quality counts: revisiting anticoagulation after mechanical aortic valve replacement in patients with atrial fibrillation	2
Temporal trends of mortality in patients with infective endocarditis: a nationwide study	2
Sharing the load to improve clinical outcomes in cardiogenic shock treated using venoarterial ECMO	2
Patient-reported outcome measures in cardiovascular disease	2
WOMANOCA calls for better ANOCA care for all	2
Stroke outcomes in patients with new onset perioperative atrial fibrillation complicating major abdominal surgery compared with patients with new onset non-perioperative atrial fibrillation	2
Loss of quality of life and increased societal costs in patients with hypertrophic cardiomyopathy: the AFFECT-HCM study	2
Need for home care or nursing home admission after myocardial infarction complicated by cardiogenic shock and/or out-of-hospital cardiac arrest	2